Search Results - "MALAMOS, Nikos A"

Phase II Trial of Biweekly Administration of Vinorelbine and Gemcitabine in Pretreated Advanced Breast Cancer by Stathopoulos, G. P.

Get full text

Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study by STATHOPOULOS, George P, RIGATOS, Sotiris K, CHRISTODOULOU, Christos, MALAMOS, Nikos A, DELIYIANNIS, Filippos, STATHOPOULOS, John G, SKARLOS, Dimosthenis V

“…This study was a phase I/II, cohort, dose-escalation trial of topotecan and paclitaxel. Its aim was to determine the dose-limiting toxicity (DLT) of the…”
Get full text

Phase ii trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer by STATHOPOULOS, George P, RIGATOS, Sotiris K, PERGANTAS, Nikos, TSAVDARIDES, Dimitris, ATHANASIADIS, Ilias, MALAMOS, Nikos A, STATHOPOULOS, John G

“…To determine the efficacy of gemcitabine (GEM) plus vinorelbine (VRL) administered biweekly in pretreated patients with advanced breast cancer. Advanced breast…”
Get full text

Inhibition of adriamycin cardiotoxicity by 5-fluorouracil: a potential free oxygen radical scavenger by Stathopoulos, G P, Malamos, N A, Dontas, I, Deliconstantinos, G, Perrea-Kotsareli, D, Karayannacos, P E

“…Adriamycin (ADR), a broad spectrum anticancer agent, has a limit to total dose used, due to cumulative cardiotoxicity. This side effect has been tested in the…”
Get more information

Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment by Stathopoulos, G P, Dafni, U G, Malamos, N A, Rigatos, S, Kouvatseas, G, Moschopoulos, N

“…This study investigates the treatment management and survival of inoperable advanced non-small cell lung cancer (NSCLC) patients. The objective was to treat…”
Get more information